Tradestie Institutional Equity Comparison Engine

MLTX vs MAZE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MAZE Overall Edge

MAZE Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Maze Therapeutics, Inc. Common Stock (MAZE) driven by superior Valuation, Momentum & Technical, Options & Structure while MLTX counters with relative strength in Growth & Margin. Fundamentally, MLTX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus MAZE at 8.5x Forward P/E and -820.8% operating margin (+0.0% YoY). In options structure, MLTX sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against MAZE sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MAZE
MLTX N/M vs MAZE 8.5x Fwd P/E
Growth & Margin Winner MLTX
Op Margin 0.0% vs -820.8% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner MAZE
1Y -5.7% vs +7.3% ยท 52W Pos 17% vs 38%
Options & Structure Winner MAZE
BREAKDOWN (7th %ile IV) vs UNCLASSIFIED (3rd %ile IV)
MLTX NASDAQ
MoonLake Immunotherapeutics Class A Ordinary Shares
Pharmaceutical Preparations
$11.85
-5.2% 1D
Market Cap $1.1B
1M Return +24.08%
1Y Return -5.65%
Forward P/E N/M
Unified AI Score
38.3 / 100 SELL
Tech 32.0 Fund 44.0 Flow 75.0 Mom 50.0
MAZE NASDAQ
Maze Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$34.16
-0.5% 1D
Market Cap $2.0B
1M Return +24.08%
1Y Return +7.29%
Forward P/E 8.5x
Unified AI Score
34.8 / 100 SELL
Tech 8.0 Fund 30.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MLTX -5.65% MAZE +7.29% Spread: +12.94 pp (MAZE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MLTX TTM Op. Margin: 0.0% MAZE TTM Op. Margin: -820.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLTX vs MAZE. Trailing 12-month operating profitability (MLTX 0.0% vs MAZE -820.8%) and valuation multiples (MLTX N/M vs MAZE 8.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MLTX (2) vs MAZE (6)
Institutional Metric MLTX MAZE Criterion Row Winner
Market Capitalization Scale $1.1B $2.0B Larger Scale MAZE
Trailing P/E Ratio Valuation N/M 8.5x Lower Multiple MAZE
Forward P/E Ratio Valuation N/M 8.5x Lower Multiple MAZE
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% -820.8% Higher Margin MLTX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -81.5% -37.5% Higher ROE MAZE
52-Week Range Position Momentum 17% ($9โ€“$23) 38% ($22โ€“$54) Stronger Trend MAZE
Beta / 30D Volatility Risk Regime 1.61ฮฒ ยท 90% Vol 0.78ฮฒ ยท 54% Vol Lower Realized Risk MAZE
Unified Institutional Score Composite Signal 38.3 / 100 (SELL) 34.8 / 100 (SELL) Higher Composite MLTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MLTX vs MAZE Buy Guide
MLTX BREAKDOWN
103d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live MLTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MAZE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live MAZE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MLTX nor MAZE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.